Search

Your search keyword '"Chiang, Shang-Lun"' showing total 35 results
Start Over Author "Chiang, Shang-Lun" Publication Year Range Last 10 years
35 results on '"Chiang, Shang-Lun"'

4. Supplementary Figures 1-2, Tables 1-2 from Up-regulation of Inflammatory Signalings by Areca Nut Extract and Role of Cyclooxygenase-2 −1195G>A Polymorphism Reveal Risk of Oral Cancer

Author

Chiang, Shang-Lun, primary, Chen, Ping-Ho, primary, Lee, Chien-Hung, primary, Ko, Albert Min-Shan, primary, Lee, Ka-Wo, primary, Lin, Ying-Chu, primary, Ho, Pei-Shan, primary, Tu, Hung-Pin, primary, Wu, Deng-Chyang, primary, Shieh, Tien-Yu, primary, and Ko, Ying-Chin, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Tables 1 - 3 from miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for Oral Squamous Cell Carcinoma Invasion and Metastasis

Author

Huang, Wei-Chieh, primary, Chan, Shih-Hsuan, primary, Jang, Te-Hsuan, primary, Chang, Jer-Wei, primary, Ko, Ying-Chin, primary, Yen, Tzu-Chen, primary, Chiang, Shang-Lun, primary, Chiang, Wei-Fan, primary, Shieh, Tien-Yu, primary, Liao, Chun-Ta, primary, Juang, Jyh-Lyh, primary, Wang, Hsueh-Chun, primary, Cheng, Ann-Joy, primary, Lu, Ya-Ching, primary, and Wang, Lu-Hai, primary

Published
2023
Full Text
View/download PDF

6. Data from miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for Oral Squamous Cell Carcinoma Invasion and Metastasis

Author

Huang, Wei-Chieh, primary, Chan, Shih-Hsuan, primary, Jang, Te-Hsuan, primary, Chang, Jer-Wei, primary, Ko, Ying-Chin, primary, Yen, Tzu-Chen, primary, Chiang, Shang-Lun, primary, Chiang, Wei-Fan, primary, Shieh, Tien-Yu, primary, Liao, Chun-Ta, primary, Juang, Jyh-Lyh, primary, Wang, Hsueh-Chun, primary, Cheng, Ann-Joy, primary, Lu, Ya-Ching, primary, and Wang, Lu-Hai, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure Legend from miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for Oral Squamous Cell Carcinoma Invasion and Metastasis

Author

Huang, Wei-Chieh, primary, Chan, Shih-Hsuan, primary, Jang, Te-Hsuan, primary, Chang, Jer-Wei, primary, Ko, Ying-Chin, primary, Yen, Tzu-Chen, primary, Chiang, Shang-Lun, primary, Chiang, Wei-Fan, primary, Shieh, Tien-Yu, primary, Liao, Chun-Ta, primary, Juang, Jyh-Lyh, primary, Wang, Hsueh-Chun, primary, Cheng, Ann-Joy, primary, Lu, Ya-Ching, primary, and Wang, Lu-Hai, primary

Published
2023
Full Text
View/download PDF

8. Supplementary Methods from miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for Oral Squamous Cell Carcinoma Invasion and Metastasis

Author

Huang, Wei-Chieh, primary, Chan, Shih-Hsuan, primary, Jang, Te-Hsuan, primary, Chang, Jer-Wei, primary, Ko, Ying-Chin, primary, Yen, Tzu-Chen, primary, Chiang, Shang-Lun, primary, Chiang, Wei-Fan, primary, Shieh, Tien-Yu, primary, Liao, Chun-Ta, primary, Juang, Jyh-Lyh, primary, Wang, Hsueh-Chun, primary, Cheng, Ann-Joy, primary, Lu, Ya-Ching, primary, and Wang, Lu-Hai, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Figures 1 - 11 from miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for Oral Squamous Cell Carcinoma Invasion and Metastasis

Author

Huang, Wei-Chieh, primary, Chan, Shih-Hsuan, primary, Jang, Te-Hsuan, primary, Chang, Jer-Wei, primary, Ko, Ying-Chin, primary, Yen, Tzu-Chen, primary, Chiang, Shang-Lun, primary, Chiang, Wei-Fan, primary, Shieh, Tien-Yu, primary, Liao, Chun-Ta, primary, Juang, Jyh-Lyh, primary, Wang, Hsueh-Chun, primary, Cheng, Ann-Joy, primary, Lu, Ya-Ching, primary, and Wang, Lu-Hai, primary

Published
2023
Full Text
View/download PDF

21. Corrigendum: ALPK1 phosphorylates myosin IIA modulating TNF-α trafficking in gout flares

Author

Lee, Chi-Pin, Chiang, Shang-Lun, Ko, Albert Min-Shan, Liu, Yu-Fan, Ma, Che, Lu, Chi-Yu, Huang, Chung-Ming, Chang, Jan-Gowth, Kuo, Tzer-Min, Chen, Chia-Lin, Tsai, Eing-Mei, and Ko, Ying-Chin

Subjects
Gout, Tumor Necrosis Factor-alpha, Nonmuscle Myosin Type IIA, Genetic Vectors, Down-Regulation, Corrigenda, Models, Biological, Monocytes, Protein Structure, Secondary, Cell Line, Uric Acid, HEK293 Cells, Protein Domains, Gene Knockdown Techniques, Cytokines, Humans, Amino Acid Sequence, Phosphorylation, Colchicine, Protein Kinases, Protein Binding
Abstract

Gout is characterized by the monosodium urate monohydrate (MSU)-induced arthritis. Alpha kinase-1 (ALPK1) has shown to be associated with MSU-induced inflammation and gout. Here, we used bioinformatics, proteomics, cell models, and twenty in vitro human assays to clarify some of its role in the inflammatory response to MSU. We found myosin IIA to be a frequent interacting protein partner of ALPK1, binding to its N-terminal and forming a protein complex with calmodulin and F-actin, and that MSU-induced ALPK1 phosphorylated the myosin IIA. A knockdown of endogenous ALPK1 or myosin IIA significantly reduced the MSU-induced secretion of tumour necrosis factor (TNF)-α. Furthermore, all gouty patients expressed higher basal protein levels of ALPK1, myosin IIA, and plasma TNF-α, however those medicated with colchicine has shown reduced myosin IIA and TNF-α but not ALPK1. The findings suggest ALPK1 is a kinase that participates in the regulation of Golgi-derived TNF-α trafficking through myosin IIA phosphorylation in the inflammation of gout. This novel pathway could be blocked at the level of myosin by colchicine in gout treatment.

Published
2016

22. Preventive effect of celecoxib use against cancer progression and occurrence of oral squamous cell carcinoma

Author

Chiang, Shang-Lun, primary, Velmurugan, Bharath Kumar, additional, Chung, Chia-Min, additional, Lin, Shu-Hui, additional, Wang, Zhi-Hong, additional, Hua, Chun-Hung, additional, Tsai, Ming-Hsui, additional, Kuo, Tzer-Min, additional, Yeh, Kun-Tu, additional, Chang, Pei-Ying, additional, Yang, Yi-Hsin, additional, and Ko, Ying-Chin, additional

Published
2017
Full Text
View/download PDF

25. Correction: Corrigendum: Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development

Author

Liu, Yu-Fan, primary, Chiang, Shang-Lun, additional, Lin, Chien-Yu, additional, Chang, Jan-Gowth, additional, Chung, Chia-Min, additional, Ko, Albert Min-Shan, additional, Lin, You-Zhe, additional, Lee, Chien-Hung, additional, Lee, Ka-Wo, additional, Chen, Mu-Kuan, additional, Hua, Chun-Hung, additional, Tsai, Ming-Hsui, additional, Chen, Yuan-Chien, additional, and Ko, Ying-Chin, additional

Published
2016
Full Text
View/download PDF

28. Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development

Author

Liu, Yu-Fan, primary, Chiang, Shang-Lun, additional, Lin, Chien-Yu, additional, Chang, Jan-Gowth, additional, Chung, Chia-Min, additional, Ko, Albert Min-Shan, additional, Lin, You-Zhe, additional, Lee, Chien-Hung, additional, Lee, Ka-Wo, additional, Chen, Mu-Kuan, additional, Hua, Chun-Hung, additional, Tsai, Ming-Hsui, additional, Chen, Yuan-Chien, additional, and Ko, Ying-Chin, additional

Published
2016
Full Text
View/download PDF

29. Acidic leucine-rich nuclear phosphoprotein-32A (ANP32A) association with lymph node metastasis predicts poor survival in oral squamous cell carcinoma patients

Author

Velmurugan, Bharath Kumar, primary, Yeh, Kun-Tu, additional, Lee, Chien-Hung, additional, Lin, Shu-Hui, additional, Chin, Mei-Chung, additional, Chiang, Shang-Lun, additional, Wang, Zhi-Hong, additional, Hua, Chun-Hung, additional, Tsai, Ming-Hsui, additional, Chang, Jan-Gowth, additional, and Ko, Ying-Chin, additional

Published
2016
Full Text
View/download PDF

32. PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.

Author

Velmurugan, Bharath K., Lee, Chien‐Hung, Chiang, Shang‐Lun, Hua, Chun‐Hung, Chen, Mei‐Chung, Lin, Shu‐Hui, Yeh, Kun‐Tu, and Ko, Ying‐Chin

Subjects
ORAL cancer, PHOSPHOPROTEIN phosphatases, TUMOR suppressor genes, SQUAMOUS cell carcinoma, MOLECULAR oncology, POST-translational modification
Abstract

Protein phosphatase 2A (PP2A) is a tumor suppressor gene, that has been frequently deactivated in many types of cancer. However, its molecular and clinical relevance in oral squamous cell carcinoma (OSCC) remain unclear. Here we show that, PP2A deactivation is a common event in oral cancer cells and hyperphosphorylation in its tyrosine-307 (Y307) residue contributes to PP2A deactivation. PP2A restoration by FTY720 treatment reduced cell growth and decreased GSK-3β phosphorylation without significantly altering other PP2A targets. We further detected PP2A phosphorylation in 262 OSCC tissues. Increased expression of p-PP2A in the tumor tissues was significantly correlated with higher N2/N3-stage (aOR = 2.1, 95%CI: 1.2-3.8). Patients with high p-PP2A expression had lower overall survival rates than those with low expression. Hazard ratio analysis showed that, high p-PP2A expression was significantly associated with mortality density (aOR = 2.2, 95%CI: 1.2-4.0) and lower 10-year overall survival (p = 0.027) in lymph node metastasis. However, no interaction was observed between p-PP2A expression and lymph node metastasis. All our results suggest that PP2A is frequently deactivated is oral cancer and determines poor outcome, restoring its expression by FTY720 can be an alternative therapeutic approach in OSCC. [ABSTRACT FROM AUTHOR]

Published
2018
Full Text
View/download PDF

35. The Long-term Lung and Respiratory Outcomes of Acid Sphingomyelinase Deficiency: A 10- and 20-year Follow-up Study.

Author

Huang YN, Chiang SL, Huang JY, Lu WL, Bau DT, Su PH, and Wang CH

Subjects
Adult, Humans, Male, Follow-Up Studies, Sphingomyelin Phosphodiesterase genetics, Lung, Niemann-Pick Disease, Type A diagnosis, Niemann-Pick Disease, Type A genetics, Niemann-Pick Diseases
Abstract

Background/aim: Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder characterized by sphingomyelin accumulation causing progressive lung disease, respiratory failure, and death., Patients and Methods: This retrospective observational study used the TriNetX database of electronic health records for 15,108 patients with ASMD from 2000-2020. After exclusions, 8,980 individuals were followed for 10 or 20 years. Outcomes included incidence and prevalence of respiratory disorders. Associations of age, sex and race were assessed., Results: Nearly all respiratory outcomes increased significantly over 20 versus 10 years. Other respiratory disorders, specified respiratory disorders and secondary pulmonary hypertension exhibited the greatest increases, reflecting progressive lung damage in ASMD. While outcomes were poor overall, older age, male sex, and racial minority status associated with greater risks, indicating differences in disease progression or care., Conclusion: This study confirms the progressive nature of ASMD and need for close monitoring and treatment of pulmonary complications to reduce long-term morbidity and mortality. Genetic testing enabling diagnosis even for milder, adult-onset forms is critical to optimize outcomes., (Copyright © 2024, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results